0650 INCIDENCE AND DURATION OF COMMON, EARLY-ONSET, TREATMENT-EMERGENT ADVERSE EVENTS OCCURRING DURING TWO RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3 STUDIES OF SODIUM OXYBATE FOR THE TREATMENT OF EXCESSIVE SLEEPINESS IN PATIENTS WITH NARCOLEPSY
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.